The Drug Enforcement Administration (DEA) will soon be proposing new rules to clarify that synthetically manufactured cannabinoids like delta-8 THC are prohibited controlled substances.
At the agency’s 2023 Supply Chain Conference earlier this month, Terrance Boos, chief of DEA’s Drug and Chemical Evaluation Section, said that officials have received “multiple petitions” on the issue and are “in the process of modifying our [regulations]” on cannabis constituents based on recommendations from the U.S. Department of Health and Human Services (HHS).
One change, Boos said in the speech, which was first noted by the law firm Vicente LLP, would be to “decontrol CBD up to 0.1 percent THC on a weight-to-weight or weight-to-volume basis.”
Based on a slideshow presentation that accompanied the speech, it appears that he was referring to plans to deschedule synthetic CBD. Hemp-derived cannabidiol that’s naturally produced is no longer regulated by DEA as long as the preparations it is contained in have no more than 0.3 percent THC by dry weight.
Via DEA.
Boos said that the intent of the forthcoming rulemaking will be to provide clarity and clear up confusion about the legal status of various cannabinoids since hemp and its derivatives were federally legalized under the
Read full article on Marijuana Moment
